Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 3.66B | 3.59B | 3.09B | 2.43B | 2.32B |
Gross Profit | 2.93B | 2.87B | 2.39B | 1.76B | 1.69B |
EBITDA | 147.36M | 144.32M | -211.73M | 64.31M | -691.54M |
Net Income | 143.88M | 177.38M | -238.72M | 13.73M | -740.94M |
Balance Sheet | |||||
Total Assets | 1.07B | 1.05B | 1.05B | 1.29B | 1.60B |
Cash, Cash Equivalents and Short-Term Investments | 317.24M | 321.03M | 338.69M | 477.85M | 733.34M |
Total Debt | 100.00M | 183.16M | 184.67M | 124.67M | 1.17B |
Total Liabilities | 576.76M | 662.50M | 805.24M | 813.51M | 1.93B |
Stockholders Equity | 497.71M | 385.82M | 240.44M | 481.05M | -332.68M |
Cash Flow | |||||
Free Cash Flow | 101.15M | -1.89M | -231.85M | -1.65M | -409.08M |
Operating Cash Flow | 121.44M | 14.98M | -216.07M | 12.96M | -389.78M |
Investing Cash Flow | -10.08M | 874.00K | 24.58M | 4.33M | 4.51M |
Financing Cash Flow | -115.16M | -33.52M | 52.34M | -272.79M | 776.34M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥1.56B | 12.26 | ― | 2.16% | -18.26% | ||
75 Outperform | ¥2.39B | 5.21 | 1.60% | 3.77% | 205.69% | ||
73 Outperform | ¥2.75B | 8.28 | 1.09% | 5.85% | -26.82% | ||
67 Neutral | ¥1.92B | 10.54 | ― | 2.45% | 95.38% | ||
63 Neutral | £1.75B | 11.25 | 2.35% | 3.21% | 0.29% | -37.72% | |
60 Neutral | ¥1.22B | 12.82 | 0.56% | 6.53% | ― | ||
49 Neutral | ¥1.20B | ― | ― | 1.72% | -170.01% |